Home
CytoSorbents

CytoSorbents Market Share Analysis for June 2026

CytoSorbents is enhancing the knowledge and clinical evidence supporting our therapies, making this information available to our partners.

Health > Health - Other

Domaincytosorbents.com

Year Founded1997

Employees201 - 500

Annual Revenue$25M - $50M

CytoSorbents

CytoSorbents (including company regionals)

cytosorbents.com

See more website traffic and engagement information

CytoSorbents Revenue up to June 2026 is 25M - 50M

revenue generated by CytoSorbents top domains

CytoSorbents top domains revenue over 3 years

Revenue for CytoSorbents top domains

cytosorbents.com25M - 50M

See more with Sales Intelligence

Total visits to CytoSorbents's top domains

Understand CytoSorbents market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cytosorbents.com4.6K

See more with Sales Intelligence

Avg. visit duration in CytoSorbents's top domains

Analyze CytoSorbents engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cytosorbents.com00:00:27

See more with Sales Intelligence

Avg. pageviews on CytoSorbents's top domains

See how CytoSorbents keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cytosorbents.com2.37

See more with Sales Intelligence

CytoSorbents top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by CytoSorbents

These are the website technologies, by industry, used by CytoSorbents top domains

Widget (7)

Twemoji

Payment & Currencies (5)

Euro

Advertising (4)

Google Adsense

Content Management System (3)

WordPress

More Technologies

10

See all

News & Signals from CytoSorbents

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCytoSorbents Corporation attends event ISICEM 2026.CytoSorbents announces HotSwap(TM) launch, renewed Aferetica partnership, and New Clinical evidence at ISICEM 2026.

NewsCytoSorbents Corporation is developing DrugSorb-ATR antithrombotic removal system on Jul 20th '26.In the U.S. and Canada, CytoSorbents is developing the DrugSorb(R)-ATR antithrombotic removal system, an investigational device based on an equivalent polymer technology to CytoSorb(R), to reduce the severity of perioperative bleeding in high-risk surgery due to blood thinning drugs.

NewsCytoSorbents Corporation is developing DrugSorb-ATR antithrombotic removal system.In the U.S. and Canada, CytoSorbents is developing the DrugSorb(R)-ATR antithrombotic removal system, an investigational device based on an equivalent polymer technology to CytoSorb(R), to reduce the severity of perioperative bleeding in high-risk surgery due to blood thinning drugs.